Skip to section navigation
Skip to page content

Trending Topic: Psychedelics

Psychedelic substances have long been touted as holding promise for treating severe and chronic forms of depression, anxiety, and posttraumatic stress disorder (PTSD). The past decade has seen another round of enthusiasm for this hope that has broadened to some other mental health conditions.

Psychedelics are also receiving more attention from decisionmakers, the media, and other members of the public because there is an emerging industry and a changing policy landscape in the United States.

Featured Research

Psychedelics and Veterans' Mental Health
The legal and policy landscape surrounding the use and supply of psychedelics is evolving rapidly. As public sentiment shifts and laws relax, the federal government must consider how best to support veterans and their health care providers.

Testimony

Improving Treatment Outcomes for Veterans with Mental Health Conditions
Current treatments for veterans experiencing PTSD and other mental health conditions are largely effective but they do not work for everyone. More treatments that yield better outcomes are needed. With sustained research investment and careful planning, psychedelic-assisted therapies hold great promise to improve care for veterans.

Multimedia

Considering Alternatives to Prohibiting Psychedelic Drugs
The RAND Epstein Family Veterans Policy Research Institute and RAND Drug Policy Research Center hosted a webinar on July 18, 2024 to present new data about the use of psychedelics in the United States. The discussion highlighted the changing policy landscape.

Recent Commentary

From the Archive